Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)

NCT00246922 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchial Asthma

Interventions

DRUG: Roflumilast

Sponsor

AstraZeneca

Collaborators

[object Object]